$TJX

Herrman Ernie sold $4.7M of TJX

Herrman Ernie (CEO & President) sold 29,549 shares of TJX COMPANIES INC /DE/ (TJX) at $157.46 ($4.65M total) on 2026-06-03.

Original reporting
SEC EDGAR · Herrman Ernie
Published Jun 5, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TJX
Neutral
medium confidence
Mentioned
$TJX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TJXNeutralLow
01

Why it matters

Traders may briefly reassess sentiment around management confidence, but the disclosure does not change TJX’s earnings outlook or guidance based on the provided facts.

02

Market read

A single insider sale at a specific price is a modest sentiment input rather than a fundamental catalyst.

03

What to watch

No context on total compensation, prior sale patterns, or whether the sale was planned for taxes/diversification; these can dominate interpretation.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-05; reflects sale executed 2026-06-03.

Background

SEC Form 4 insider transaction disclosure for TJX; CEO & President sold shares in an open-market transaction.

Company-level read

Ticker impact

$TJXNeutralMedium confidence
Context

TJX CEO & President Ernie Herrman filed an open-market sale of 29,549 shares at ~$157.46 on 2026-06-03.

Expected impact

Limited near-term impact; any reaction likely fades unless accompanied by other negative catalysts.

Evidence & confidence

The filing is a routine insider transaction (no 10b5-1 plan stated) but provides no new operating/financial information.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Insider sales are often diversification or liquidity-driven; without a 10b5-1 plan, the transaction still may not imply bearish expectations.

Key entities

  • TJX COMPANIES INC /DE/

    Subject of the Form 4 insider sale by CEO & President Ernie Herrman.

  • Herrman Ernie

    CEO & President who sold 29,549 TJX shares at ~$157.46.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TJXHighAI 8/10

TJX Raises Fiscal 2027 Outlook as Q2 Results Show Broad-Based Growth

TJX raised its fiscal 2027 profit and earnings outlook after Q2 results exceeded expectations. Adjusted earnings rose 11% to $1.22 per share, and net sales increased 5% to $15.18 billion. Management also increased its long-term store target. Marmaxx, the largest division, showed the weakest growth at 1%, while other divisions performed better.

$TJXMedAI 8/10

Should Investors Buy TJX as Growth Improves but Valuation Stays Rich?

TJX reported strong Q2 results with rising sales and raised its fiscal 2027 earnings guidance to $5.15-$5.20 per share. The company plans to expand its store count to 7,500 and accelerate growth. However, its valuation remains high, with a forward P/S ratio of 2.06, above industry and historical averages. TJX's cash flow and shareholder returns are robust, but execution and cost pressures remain risks.

$TJXHighAI 8/10

TJX Falls 17.4% in the Past Month as Strong Results Meet Key Risks

TJX Companies Inc. (TJX) shares fell 17.4% in the past month despite beating Q2 earnings estimates and raising its full-year outlook. Q2 sales rose 5% to $15.18B, but Marmaxx's 1% comparable sales growth missed expectations. Management cited merchandise mix issues. TJX faces cost pressures from wages, fuel, and currency fluctuations, with Q3 gross margin expected to decline. The stock's valuation remains high, trading at a premium to its sub-industry and historical median.

$TJXMed

Tjx stock hits 52-week low at 125.5 USD

TJX Companies' stock hit a 52-week low of $125.49, down 26% from its high. Despite a 1-year decline of 9.66% and YTD losses of 17%, InvestingPro suggests it may be undervalued. Q2 fiscal 2027 results beat estimates, with $15.2B revenue and $1.22 EPS. Analysts have mixed views, with Jefferies downgrading to Hold, Bernstein maintaining Outperform, and UBS raising its target to $198.